TY - DATA
T1 - Data underlying the publication:  Radiofrequency ablation for thyroid nodules (RATED study) - analysis of a learning curve and predictors of success
PY - 2025/01/10
AU - M. Van der Meeren
AU - Tim Boers
AU - P. de Graaf
AU - K.  Duvivier
AU - K.  Dreijerink
AU - L. Deden
AU - P. Veendrick
AU - P. Cernohorsky
AU - F. Joosten
AU - B. Savelberg
UR - 
DO - 10.4121/dd66122a-77c2-4f05-a34a-6b5aed8223e0.v2
KW - Thyroid nodule
KW - RFA
KW - retrospective study
KW - table
N2 - <p><em>Context </em>Radiofrequency ablation (RFA) is used as treatment for symptomatic thyroid nodules. However, factors influencing the volume reduction ratio (VRR) at 12 months are not yet fully understood. <em>Objective </em>The primary objective was evaluating the VRR at 12 months after RFA. Secondary objectives were the assessment of a learning curve and factors influencing the VRR at 12 months. <em>Design </em>This is a retrospective Dutch multi-center study. <em>Patients and intervention </em>Patients who underwent RFA for symptomatic thyroid nodules with available ultrasound follow-up were eligible for this study. <em>Main outcome measures </em>Ultrasound based VRR at 12 months and chronologically numbered RFA procedures. All patients’ baseline, ultrasound, treatment, and early follow-up factors were assessed for correlation with VRR at 12 months.&nbsp;</p>
ER -